- Contractors
- Abviro LLC
Abviro LLC
Federal contractor · Research and Development in Biotechnology
Abviro has 2 federal contracts of $100,000 or more active since October 2023, with $40.5M obligated, from 1 agency. 1 is still running, 1 ending within 18 months.
- Contracts
- 2 since FY2024$40,510,113 obligated, contracts of $100,000 or more
- Running now
- 1 contract
- Biggest customer
- National Institutes of Health$40.5M on 2 contracts
- Main industry
- Research and Development in BiotechnologyNAICS 541711
- UEI
- K3L6KXJ9B6M7Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| To Conduct a Phase 2 Dengue Human Challenge Clinical Trial of Abviro Anti-Dengue Monoclonal Antibody (Mab) Av-1.National Institutes of Health · 75N93023C00055 | $11,335,102 | Dec 31, 2026in 1 month | MD |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| National Institutes of Health2 contracts | $40,510,113 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in BiotechnologyNAICS 541711 · 1 contract | $29,175,011 | |
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 · 1 contract | $11,335,102 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| Maryland2 contracts | $40,510,113 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at National Institutes of Health: see the list.
Get new notices like Abviro's work
New contract opportunities under NAICS 541711, research and development in biotechnology, the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy